InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)
InMed Pharmaceuticals (INM) posted quarterly Asset Utilization Ratio of 0.37 for Q4 2025, down 27.95% year-over-year from 0.51 in Q4 2024, and up 10.71% quarter-over-quarter from 0.33 in Q3 2025.
InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.37 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio fell 27.95% year-over-year to 0.37; the TTM figure through Dec 2025 stood at 0.37 (down 27.95% YoY), while the FY2025 annual figure was 0.36, up 1.72% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.37, up from 0.33 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.55 in Q1 2025, with the low at 0.12 in Q4 2022.
- The 4-year median for Asset Utilization Ratio is 0.37 (2023), against an average of 0.35.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio jumped 246.64% in 2023, then fell 27.95% in 2025.
- InMed Pharmaceuticals' Asset Utilization Ratio stood at 0.12 in 2022, then surged by 246.64% to 0.42 in 2023, then climbed by 21.52% to 0.51 in 2024, then dropped by 27.95% to 0.37 in 2025.
- Business Quant data shows INM's Asset Utilization Ratio at 0.37 in Q4 2025, 0.33 in Q3 2025, and 0.4 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.42 Mn | 1.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.37 |
| Sep 30, 2025 | 0.33 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | 0.55 |
| Dec 31, 2024 | 0.51 |
| Sep 30, 2024 | 0.45 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.42 |
| Sep 30, 2023 | 0.38 |
| Jun 30, 2023 | 0.29 |
| Mar 31, 2023 | 0.15 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.12 |